New mRNA tech takes aim at the flu
NCT ID NCT05829356
Summary
This early-stage study tested the safety and immune response of a new mRNA flu vaccine in adults. Researchers gave 159 participants one of several doses of the experimental vaccine or a standard flu shot to compare side effects and antibody levels. The goal was to gather data to help design better mRNA vaccines for future flu seasons.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA IMMUNIZATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Investigational Site Number : 0360001
Morayfield, Queensland, 4506, Australia
-
Investigational Site Number : 0360002
Camberwell, Victoria, 3124, Australia
-
Investigational Site Number : 0360003
Adelaide, 5000, Australia
-
Investigational Site Number : 0360004
Herston, Queensland, 4006, Australia
-
Investigational Site Number : 8260001
London, London, City of, SW10 9NH, United Kingdom
-
Investigational Site Number : 8260002
Leicester, Leicestershire, LE1 5WW, United Kingdom
-
Investigational Site Number : 8260003
Sheffield, Sheffield, S10 2JF, United Kingdom
-
Investigational Site Number : 8260004
London, London, City of, W12 0HS, United Kingdom
Conditions
Explore the condition pages connected to this study.